Sitka Blog Sitka Biopharma Announces New Investment from Global Health Sciences Fund
Vancouver, Canada: Sitka Biopharma is pleased to announce that Quark Venture Inc. and GF Securities, through their Global Health Sciences Fund (GHS), has invested $1.9M into Sitka - financing that will enable the company to complete critical GLP toxicology studies and GMP manufacture of clinical drug product. This in turn will allow Sitka and partner [...]
Read full article »
Sitka Biopharma focuses on developing a nanoparticle platform to increase drug absorption of difficult-to-penetrate tissues in cancer treatments.
Read more